• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR ABSOLUTE PRO VASCULAR; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR ABSOLUTE PRO VASCULAR; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Model Number 1012530-80
Device Problem Material Deformation (2976)
Patient Problems Hemorrhage/Bleeding (1888); Perforation (2001)
Event Date 10/22/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).The stent remains implanted.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported that this was a procedure performed to treat a chronic total occlusion in the right iliac artery.Patient anatomy included two previously implanted stents.Pre dilatation was performed and an 8x80 absolute pro vascular stent was implanted without issue.A second absolute pro vascular stent was implanted proximally, overlapping the first stent, and routine post dilatation was performed.It was noted that the 8x80 stent appeared misshapen, as if it was bulging out and it was observed that a perforation occurred, with the stent extending outside the perforated artery.Massive hemorrhage was seen, and a non-abbott covered stent was implanted to seal the perforation; however, the bleeding continued.A dissection was noted outside the stented area.Prolonged balloon dilatation was performed, and the patient was air-lifted to a second facility.A surgical procedure was performed to repair the iliac artery.The non-abbott covered stent remained patent and no additional intervention was performed, related to the issue with the absolute pro vascular stent.Post surgical procedure, the patient was in stable condition.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other complaints.The reported patient effects of perforation and hemorrhage, as listed in the absolute pro instructions for use (ifu), are known possible adverse events that may be associated with the use of a stent in peripheral arteries and / or biliary tree.The investigation was unable to determine a cause for the reported difficulties.It may be possible that use of the larger diameter stent may have contributed to the difficulties reported including the misshapen appearance of the stent and the cascading patient effects that occurred after implant and post dilation.However, without having angiograms to evaluate, a definitive cause for the difficulties could not be determined.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSOLUTE PRO VASCULAR
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key9301474
MDR Text Key165980937
Report Number2024168-2019-13399
Device Sequence Number1
Product Code NIP
UDI-Device Identifier08717648175725
UDI-Public08717648175725
Combination Product (y/n)N
PMA/PMN Number
P110028
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 02/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/31/2021
Device Model Number1012530-80
Device Catalogue Number1012530-80
Device Lot Number8062861
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 10/22/2019
Initial Date FDA Received11/08/2019
Supplement Dates Manufacturer Received02/14/2020
Supplement Dates FDA Received02/20/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-